RELATED STORY | Weight-loss pill from Wegovy makers cut body weight by up to 13% in early trial "We are pleased the FDA has declared that supply of the only real, FDA-approved semaglutide medicines is resolved, affirming that Novo Nordisk is meeting or exceeding current and projected nationwide demand
Additionally, the provider can apply topical numbing cream to the injection area to minimize the discomfort
These drugs bind to the GLP-1 receptor and: Lower blood sugar by increasing insulin and reducing glucagon Slow gastric emptying Reduce appetite and food cravings Support clinically significant weight loss in many people They are commonly prescribed for: Type 2 diabetes Obesity or overweight with weight-related health risks Trials suggest GLP-1 agonists can reduce body weight by around 5 to 18 per cent on average, often with improvements in blood pressure, cholesterol and other cardiometabolic markers
I suggest at least 2 sessions a week for the first 3 weeks
Common side effects: nausea, fullness, reflux, constipation/diarrhea
Even better, by assisting them in developing healthy eating habits in a positive environment, where they can see results, nutritionists can also reduce the odds they will need any GLP-1 intervention in the future